Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
- Wang C. , et al.
2. Historical insights of polyphenols in human health
- Quero J. , et al.
3. Sappanone A alleviates metabolic dysfunction-associated steatohepatitis by decreasing hepatocyte lipotoxicity via targeting Mup3 in mice
- Zhu A. , et al.
4. Impacts of Supplementation with Silymarin on Cardiovascular Risk Factors: A Systematic Review and Dose–Response Meta-Analysis
- Mohammadi S. , et al.
6. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
- Malik A. , et al.
7. Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
- de Avelar C.R. , et al.
8. Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
- Chantarojanasiri T. , et al.
9. Silymarin and management of liver function in nonalcoholic steatohepatitis: a case report
- Hashem A. , et al.
10. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
- Nucera S. , et al.
11. Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
- Lee Y.Y. , et al.
12. Effect of medicinal plants and natural products on liver enzymes in non-alcoholic fatty liver patients in iran: A systematic review and meta-analysis
- Fakhri M. , et al.
13. Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial
- Atarodi H. , et al.
14. The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease
- Poulos J.E. , et al.
15. Antioxidative effects of silymarin on the reduction of liver complications of fingolimod in patients with relapsing–remitting multiple sclerosis: A clinical trial study
- Ghiasian M. , et al.
16. Nano- and Microsized Forms of Silymarin and Silybin
- Poltavets Y.I. , et al.
17. NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
- Marušić M. , et al.
18. Silymarin in combination with vitamin C, vitamin E, coenzyme q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients
- Curcio A. , et al.
19. The effects of realsil (Silybin–phospholipid–vitamin e complex) on liver enzymes in patients with non-alcoholic fatty liver disease (nafld) or nonalcoholic steato-hepatitis (nash): A systematic review and meta-analysis of rcts
- Derakhshandeh-Rishehri S.M. , et al.
20. Role of silymarin in the management of non-alcoholic fatty liver disease: Time to clear the mist
- Roy K. , et al.
21. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
- Abenavoli L. , et al.
22. Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen
- Emami H. , et al.
23. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials
- Zhong S. , et al.